Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry

醫療器械板塊普遍隨A股同業造好 啟明、愛康及復銳醫療漲10%-15%
The medical device sector generally increased by 10% and 15% along with the creation of Qiming, Aikang and Fu Rui Medical in the A-share industry.

缸邊情報 ·  {{timeTz}}

滬指及深成僅反覆回升0.2%,但內地醫療器械、醫藥生物、流感及病毒防治板塊升2.2%-3.9%。

Prev and Shenzhen only repeatedly rebounded 0.2%, but the mainland medical devices, medical biology, influenza and virus prevention and control sector rose 2.2% 3.9%.

本港除醫藥板塊跑贏外,醫療器械板塊也普遍造好,尤其是復銳醫療科技(01696.HK)由近九個月低位連升第二天,今天股價重越10天及20天線,最高見10.32元,現報10.18元,急漲近15%。

In addition to the outperformance of the pharmaceutical sector in Hong Kong, the medical device sector is also generally good. In particular, the stock price of 01696.HK has risen from a nine-month low for the second day in a row. Today, its share price has surpassed 10 days and 20 antennas, reaching a peak of 10.32 yuan, which is now trading at 10.18 yuan, a sharp rise of nearly 15%.

愛康醫療(01789.HK)終止四連跌,股價由近兩年半低位反彈高見6.28元,現報6.24元,反彈12%。啟明醫療(02500.HK)由上市低位連升第二天,今天股價重越10天及20天線(27.53元),最高見29.6元,現報28.4元,續升10%。

Aikang Medical (01789.HK) ended four consecutive declines, shares rebounded from nearly two and a half years low as high as 6.28 yuan, now trading at 6.24 yuan, rebounding 12%. Qiming Medical (02500.HK) rose the second day after its listing low, and today its share price rose 10 days and 20 antennas (27.53 yuan), reaching a peak of 29.6 yuan. It is now trading at 28.4 yuan, up 10%.

海吉亞醫療(06078.HK)由低位反覆回升,最高見46.35元,現報46.1元,回升7.3%。醫渡科技(02158.HK)由上市低位連升第三天,今天股價重越10天及20天線(20.83元),最高見22.15元,現報21.85元,續升7.1%。

Hagia Medical (06078.HK) has repeatedly rebounded from its low level, reaching a maximum of 46.35 yuan. It is now at 46.1 yuan, a rise of 7.3%. Yidu Technology (02158.HK) rose for the third day in a row from its low listing level, and today its share price has surpassed 10 days and 20 antennas (20.83 yuan), reaching a maximum of 22.15 yuan. It is now trading at 21.85 yuan, up 7.1 percent.

微創醫療(00853.HK)、貝康醫療(02170.HK)及心通醫療(02160.HK)升逾3%-4%,分別高見26.85元、6.7元及4元。(sz)~

Minimally invasive medical care (00853.HK), Baykang Medical (02170.HK) and Heart Care (02160.HK) rose by more than 3% Mur4% to 26.85,6.70 and 4 yuan respectively. (sz) ~

This page is machine-translated. Moomoo tries to improve but do not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.

This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors’ financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. Moomoo makes no representation or warranty as to its adequacy, completeness, accuracy or timeliness for any particular purpose of the above content.

Moomoo is a financial information and trading app offered by Moomoo Technologies Inc.
In the U.S., investment products and services available through the moomoo app are offered by Moomoo Financial Inc., a broker-dealer registered with the U.S. Securities and Exchange Commission (SEC) and a member of Financial Industry Regulatory Authority (FINRA)/Securities Investor Protection Corporation (SIPC).
In Singapore, investment products and services available through the moomoo app are offered through Moomoo Financial Singapore Pte. Ltd. regulated by the Monetary Authority of Singapore (MAS). Moomoo Financial Singapore Pte. Ltd. is a Capital Markets Services Licence (License No. CMS101000) holder with the Exempt Financial Adviser Status. This advertisement has not been reviewed by the Monetary Authority of Singapore.
In Australia, financial products and services available through the moomoo app are provided by Futu Securities (Australia) Ltd, an Australian Financial Services Licensee (AFSL No. 224663) regulated by the Australian Securities and Investment Commission (ASIC). Please read and understand our Financial Services Guide, Terms and Conditions, Privacy Policy and other disclosure documents which are available on our websites https://www.futuau.com and https://www.moomoo.com/au. Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd. and Futu Securities (Australia) Ltd are affiliated companies.